Latest Period
Q2 2026
Security Snapshot
GLOBUS MEDICAL INC - Class A Stock (GMED) Institutional Ownership
CUSIP: 379577208
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
591
Shares (Excl. Options)
118,801,241
Price
$79.01
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Stock
- Symbol
- GMED on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 118,801,241
- Total 13F value
- $9,414,190,243
- Portfolio coverage rank
- 0.01%
- Share change
- +8,886,132
- Value change
- +$673,078,141
- Number of holders
- 591
- Shares outstanding
- 115,244,363
- SEC-reported price per share
- $80.58
- Insider filing price
- $80.58
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- GMED - GLOBUS MEDICAL INC - Class A Stock is tracked under CUSIP 379577208.
- 591 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 603 to 591 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $9,426,440,897 to $9,414,190,243.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 591 institutions filings for Q2 2026.
Security key
379577208
Latest holder period
Q2 2026
13F holders
591
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
GMED full holder history
GLOBUS MEDICAL INC SEC filings
GLOBUS MEDICAL INC company facts
GLOBUS MEDICAL INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 379577208:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
GMED
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 9.1% | +16% | $778,991,964 | -$11,095,352 | 10,487,237 | -1.4% | BlackRock, Inc. | 31 Mar 2025 |
| JANUS HENDERSON GROUP PLC | 6.1% | +5% | $522,135,958 | +$30,787,723 | 7,029,294 | +6.3% | JANUS HENDERSON GROUP PLC | 31 Mar 2025 |
As of 30 Jun 2026, 591 institutional investors reported holding 118,801,241 shares of GLOBUS MEDICAL INC - Class A Stock (GMED). This represents 103% of the company’s total 115,244,363 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
64%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.4% | 10,806,724 | +2.9% | 0.01% | $853,839,261 |
| Jupiter Topco LLC | 7.1% | 8,200,423 | 0% | 0.26% | $647,930,962 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 5,107,532 | +1.5% | 0.01% | $403,546,103 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.3% | 4,994,385 | +2.4% | 0.02% | $394,606,359 |
| Invesco Ltd. | 3.7% | 4,309,771 | -0.16% | 0.03% | $340,515,006 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 3.7% | 4,279,730 | 1.1% | $338,141,467 | |
| STATE STREET CORP | 3.2% | 3,714,029 | +3.4% | 0.01% | $293,540,630 |
| Sculptor Capital LP | 2.6% | 3,000,000 | -1.9% | 2.5% | $237,030,000 |
| JPMORGAN CHASE & CO | 2.4% | 2,743,850 | +5.7% | 0.01% | $230,761,440 |
| BANK OF MONTREAL /CAN/ | 2.1% | 2,425,491 | +5.1% | 0.07% | $191,638,042 |
| ALLIANCEBERNSTEIN L.P. | 2.1% | 2,380,344 | +36% | 0.08% | $205,090,439 |
| DIMENSIONAL FUND ADVISORS LP | 2.1% | 2,369,310 | +34% | 0.03% | $187,250,224 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 2,153,014 | +1.9% | 0.01% | $170,151,584 |
| GOLDMAN SACHS GROUP INC | 1.5% | 1,781,608 | +57% | 0.01% | $140,764,853 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.5% | 1,716,621 | +88% | 0.06% | $135,630,225 |
| Boston Trust Walden Corp | 1.4% | 1,573,361 | +25% | 0.95% | $124,311,253 |
| Allspring Global Investments Holdings, LLC | 1.4% | 1,571,681 | +267% | 0.18% | $119,384,889 |
| Boston Partners | 1.3% | 1,554,990 | 0.11% | $122,847,510 | |
| GW&K Investment Management, LLC | 1.3% | 1,453,206 | -2.8% | 0.9% | $114,818,000 |
| GENEVA CAPITAL MANAGEMENT LLC | 1.2% | 1,417,067 | -20% | 2.6% | $111,962,440 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.1% | 1,284,896 | -36% | 0.31% | $101,519,633 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1% | 1,246,322 | +0.22% | 0.01% | $98,471,901 |
| Quantinno Capital Management LP | 1.1% | 1,219,098 | +123% | 0.12% | $96,320,933 |
| NORGES BANK | 0.98% | 1,127,051 | 0.01% | $89,048,300 | |
| FULLER & THALER ASSET MANAGEMENT, INC. | 0.97% | 1,114,484 | +1.2% | 0.24% | $88,055,393 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 118,801,241 | $9,414,190,243 | +$673,078,141 | $79.01 | 591 |
| 2026 Q1 | 109,483,450 | $9,426,440,897 | -$146,628,563 | $86.16 | 603 |
| 2025 Q4 | 111,087,339 | $9,706,953,561 | +$150,539,278 | $87.31 | 560 |
| 2025 Q3 | 115,933,964 | $6,654,707,679 | +$72,456,317 | $57.27 | 488 |
| 2025 Q2 | 114,075,801 | $6,730,550,265 | +$195,769,879 | $59.02 | 477 |
| 2025 Q1 | 109,345,858 | $7,997,914,722 | -$8,993,495 | $73.20 | 507 |
| 2024 Q4 | 108,904,887 | $9,007,980,911 | +$44,310,752 | $82.71 | 495 |
| 2024 Q3 | 108,072,594 | $7,734,964,942 | -$332,078,125 | $71.54 | 444 |
| 2024 Q2 | 112,764,178 | $7,722,959,830 | -$3,143,182 | $68.49 | 443 |
| 2024 Q1 | 113,402,229 | $6,082,679,016 | +$359,376,321 | $53.64 | 435 |
| 2023 Q4 | 106,692,854 | $5,685,431,048 | -$155,605,070 | $53.29 | 405 |
| 2023 Q3 | 109,414,808 | $5,433,176,387 | +$1,362,204,600 | $49.65 | 426 |
| 2023 Q2 | 81,374,906 | $4,843,899,307 | +$408,515,363 | $59.54 | 378 |
| 2023 Q1 | 74,600,238 | $4,224,726,594 | -$151,471,403 | $56.64 | 381 |
| 2022 Q4 | 75,948,098 | $5,639,196,814 | +$86,702,611 | $74.27 | 383 |
| 2022 Q3 | 74,451,382 | $4,436,437,568 | +$100,448,577 | $59.57 | 356 |
| 2022 Q2 | 72,222,203 | $4,054,750,490 | +$112,004,727 | $56.14 | 349 |
| 2022 Q1 | 69,530,797 | $5,130,106,470 | +$81,009,114 | $73.78 | 366 |
| 2021 Q4 | 68,345,177 | $4,935,105,853 | +$7,508,095 | $72.20 | 367 |
| 2021 Q3 | 67,700,811 | $5,190,187,299 | -$70,035,321 | $76.62 | 380 |
| 2021 Q2 | 68,045,932 | $5,276,020,366 | +$27,082,820 | $77.53 | 351 |
| 2021 Q1 | 67,739,467 | $4,178,223,997 | +$52,788,626 | $61.67 | 338 |
| 2020 Q4 | 66,616,139 | $4,344,582,646 | +$137,526,882 | $65.22 | 343 |
| 2020 Q3 | 64,418,606 | $3,189,910,125 | -$115,537,152 | $49.52 | 336 |
| 2020 Q2 | 66,705,847 | $3,180,329,751 | -$236,172,306 | $47.71 | 312 |